『GLP-1 Drugs and Sleep Apnea — A Breakthrough?』のカバーアート

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

著者： Inception Point Ai
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Host Julia Cartwright explores how GLP-1 weight loss drugs are revolutionizing obstructive sleep apnea treatment, following tirzepatide's groundbreaking FDA approval. From clinical trial results to biological mechanisms and access barriers, this series examines whether these drugs offer real hope beyond the CPAP machine for millions of Americans.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright

    GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright
    2026/04/07
    Join host Julia Cartwright as she explores the surprising connection between GLP-1 medications and sleep apnea treatment. Discover how this emerging drug class is challenging traditional approaches to one of America's most common sleep disorders, offering new hope beyond weight loss.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    1 分
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Who Gets Left Behind?

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Who Gets Left Behind?
    2026/04/07
    Julia Cartwright examines who gets left behind as tirzepatide becomes the first FDA-approved drug for sleep apnea with obesity. We discuss cost barriers, insurance gaps, and equity concerns surrounding this breakthrough treatment, covering real-world access challenges that prevent many patients from benefiting despite promising trial results.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    27 分
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - More Than Just Weight Loss

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - More Than Just Weight Loss
    2026/04/07
    Host Julia Cartwright explores how tirzepatide, the first FDA-approved medication for obstructive sleep apnea, works beyond simple weight loss. Drawing on SURMOUNT-OSA trial data, the episode examines emerging evidence that these GLP-1 drugs may combat sleep apnea through multiple pathways: reducing airway inflammation, improving insulin sensitivity, and potentially influencing brain receptors that regulate breathing and sleep patterns during rest.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    26 分
まだレビューはありません